Provider perspectives on HPV vaccine hesitancy in the post-COVID-19 era

Provider perspectives on HPV vaccine hesitancy in the post-COVID-19 era

While HPV vaccination is effective in prevention of many HPV-associated cancers, only 61.4% of US adolescents were up to date on their HPV vaccinations in 2023. In the period following the COVID-19 pandemic, a decrease in vaccine uptake was reported, along with a rise in vaccine hesitancy. This stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Thao N. Hoang, Denny Fe G. Agana-Norman, Aylia S. Rizvi, Christine D. Hsu, Fangjian Guo, Victor Adekanmbi, Abbey B. Berenson
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human papillomavirus
HPV
vaccination
vaccine
vaccine Hesitancy
COVID-19
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2550054
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items